XYLOSE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Xylose, and when can generic versions of Xylose launch?
Xylose is a drug marketed by Lyne and is included in one NDA.
The generic ingredient in XYLOSE is xylose. There is one drug master file entry for this compound. Additional details are available on the xylose profile page.
Summary for XYLOSE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 73 |
Clinical Trials: | 4 |
Patent Applications: | 2,975 |
Formulation / Manufacturing: | see details |
DailyMed Link: | XYLOSE at DailyMed |
Recent Clinical Trials for XYLOSE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Sintesi Research Srl | Phase 2 |
Indena S.p.A | Phase 2 |
L'Oreal | N/A |
US Patents and Regulatory Information for XYLOSE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lyne | XYLOSE | xylose | POWDER;ORAL | 018856-001 | Mar 26, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |